110 results
Page 3 of 6
6-K
EX-99.1
b27emwjywh64 g6
21 Nov 16
Current report (foreign)
12:00am
20-F/A
EX-4.40
d1v45p36
31 May 16
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.39
9o4nur2nvtv1xl
22 Sep 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.38
0uocwnnt
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
mdqwkgga94
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.39
uhp8t8e7l8wnk9d5
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-99
5j8sh6u3wqx9
6 Mar 15
BioLineRx Prices $25 Million Underwritten Public Offering
12:00am
424B5
zreirml1cqopxnaiv
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
j09015ggsv2i
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
z0322
5 Mar 15
Current report (foreign)
12:00am